Conclusions
- This is the most extensive profiling study to investigate the expression of clock genes in HCC.
- Our data show that clock genes expression impacts patient survival and is associated with alterations in immune-related gene expression and TIS score which suggest a role in the modulation of anti-tumor immunity.
- These results support the clock pathway role as a oncogenic driver and its potential as a therapeutic target in HCC.